MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview at the 28th Annual Cowen and Company Health Care Conference on March 17 in Boston. The GTx presentation, which will highlight the company’s clinical development programs and the recently announced results of the ACAPODENE® 80 mg Phase III ADT clinical trial, will begin at 4:45 p.m. Eastern Time. A simultaneous webcast of the presentation will be accessible from the GTx website at www.gtxinc.com. An archived replay of the presentation will be available on the company website until March 24.
